4
Changes in Ownership
Foghorn Therapeutics Inc. Filed Acc 0001562180-24-006632
Options or other derivatives
- Chief Business Officer acquired 190,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rivkin Anna Chief Business Officer | 2024-09-03 | Grant or award · Stock Options (Right to buy) | +190,000 | $7.85 | $1,491,500 | 190,000 | D |
Loading xslF345X05/primarydocument.xml…